Wilterding Mark
Wilterding Mark, CFO, reported a transaction classified as grant at RxSight, Inc. involving 258770.000000 shares. Reported holdings after the transaction were 258770.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 05, 2026
- Filing date
- Sep 10, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingRXST price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001193125-26-386841 Stock Option (right to buy)
- Transaction date
- Sep 05, 2026 Filed Sep 10, 2026, 12:55 AM · 5d delay
- Shares
- 258,770 sh Price unknown
- Estimated value
- — Computed from shares × price
- Holdings after
- 258,770 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-18 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - missing_price-8 points
price_cents is null
Missing price reduces confidence in value-based signals.
- price_cents
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Financial Officer
- F1
Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subjec…
- F2
On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1:1 basis with a post-exchange exercise price of $6.3…
- F3
Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the shares subje…
0 other transactions
0 recent txs